A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae (Q42664352)
Jump to navigation
Jump to search
scientific article published on September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae |
scientific article published on September 2008 |
Statements
1 reference
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae (English)
1 reference
Krasimir Vasilev
1 reference
Galina Reshedko
1 reference
Remus Orasan
1 reference
Miguel Sanchez
1 reference
Juri Teras
1 reference
Tim Babinchak
1 reference
Gary Dukart
1 reference
Angel Cooper
1 reference
Nathalie Dartois
1 reference
Hassan Gandjini
1 reference
Russ Orrico
1 reference
Evelyn Ellis-Grosse
1 reference
309 Study Group
1 reference
1 September 2008
1 reference
1 reference
Identifiers
1 reference